Itraconazole USP For Compounding (API)

Itraconazole USP is an active pharmaceutical ingredient used in medications to treat fungal infections. It belongs to a class of medications known as azole antifungals and works by inhibiting the growth of certain types of fungi. It is commonly used to treat infections of the skin, nails, mouth, and respiratory system. Itraconazole USP is approved by the United States Pharmacopeia (USP), which sets quality standards for pharmaceutical ingredients.

Itraconazole USP is used for compounding purposes to formulate medication in customized doses and forms for specific patient needs. It is an antifungal medication that is used to treat various fungal infections, such as aspergillosis, histoplasmosis, and onychomycosis. In compounding, it may be combined with other inactive ingredients to create creams, ointments, or oral suspensions for easier administration and absorption in patients. It may also be used to treat fungal infections in special populations, such as children or those with underlying medical conditions that may limit treatment options.

CAS Number: 84625-61-6

Property: Light Sensitive